Navigation Links
ARISTOTLE trial finds new drug may revolutionize the treatment of atrial fibrillation
Date:10/25/2011

Vancouver New research has the potential to revolutionize the treatment of atrial fibrillation (AF), a condition affecting a quarter of a million Canadians which is expected to strike even more in the coming years, as the Canadian population ages.

AF is the most common type of heart arrhythmia and puts those affected at a three to five times greater risk for stroke. Now, there is a new drug poised to battle the condition.

"The majority of patients with atrial fibrillation need an anticoagulant. The current anticoagulant can be a burden for physicians and patients due to its side effects and narrow therapeutic range," Dr. Justin Ezekowitz, from the University of Alberta, told a late breaking clinical trial session at the Canadian Cardiovascular Congress 2011, co-hosted by the Heart and Stroke Foundation of Canada and the Canadian Cardiovascular Congress. It is associated with a risk of bleeding and needs very close monitoring, whereas this new drug is taken twice a day and does not require monitoring. Our trial also shows it is not just equivalent, but better than warfarin for preventing strokes. These are important advantages."

The mainstay of treatment for AF, in which the heart's rhythm becomes very irregular and rapid, has been warfarin, an anticoagulant which has been highly effective in preventing stroke in patients with AF. However, it requires patients to come in to their doctor's office for frequent blood tests, is associated with bleeding, and it also can interact with a variety of foods and drugs that patients might also be taking. Apixaban, a new type of oral anticoagulant known as a factor Xa inhibitor, resulted in fewer strokes (ischemic or hemorrhagic) and fewer systemic embolisms, caused less bleeding and resulted in fewer deaths in patients with atrial fibrillation, said Dr. Ezekowitz.

"We have a drug that can increase reductions in death and stroke and it is safer in terms of bleeding," says Dr. Ezekowi
'/>"/>

Contact: Amanda Bates
amanda@curvecommunications.com
604-306-0027
Heart and Stroke Foundation of Canada
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. HIV Medication Patch Shows Promise in Early Trial
2. Weight Gain Might Raise Endometrial Cancer Risk
3. Significant weight gain in adulthood increased risk for endometrial cancer
4. Timing for clinical trials for stem cell therapy in spinal cord injuries is right
5. Penn-developed online informed consent tool could boost number of patients in cancer clinical trials
6. Major HIV prevention trial in women to drop oral tenofovir arm
7. Company stock prices before public announcements of oncology trial results
8. Smaller, faster trials can improve cancer patient survival
9. Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial
10. First Phase III trial of an alpha-pharmaceutical
11. TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... The report "Higher Education Market [Software Solutions, ... Technology, Student & Curriculum, Performance Management] - Worldwide ... the global Higher Ed market into various sub-segments ... sizes. The report also identifies the factors driving ... along with the adoption trends. , Browse ...
(Date:8/22/2014)... 2014 A new study finds a wide range ... be related to key environmental exposuresin children with Crohn,s disease ... journal of the Crohn,s & Colitis Foundation of America ... Williams & Wilkins , a part of Wolters Kluwer ... of alterations of DNA in several regions of the genome ...
(Date:8/22/2014)... disease can be slowed and some of its ... found in pomegranate. Also, the painful inflammation ... Parkinson,s disease could be reduced, according to the ... of Huddersfield scientist Dr Olumayokun Olajide, who specialises ... Now, a new phase of research can explore ...
(Date:8/22/2014)... at New York University,s Langone Medical Center (NYULMC) heroically ... youngest and most vulnerable down flights of stairs during ... by Hurricane Sandy. , Now, a recent study ... Nursing (NYUCN) and of Dentistry (NYUCD), published in ... on NYULMC nurses, post-Sandy deployment to help address patient ...
(Date:8/22/2014)... for Medical Oncology (ESMO), the leading pan-European organisation ... of three outstanding individuals receiving the Society,s esteemed ... Carsten Bokemeyer, Heikki Joensuu and Peter Boyle on ... September, Madrid, Spain. , Carsten Bokemeyer will receive ... the transition of cancer discovery into real benefit ...
Breaking Medicine News(10 mins):Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Study shows epigenetic changes in children with Crohn's disease 2Health News:Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 3Health News:ESMO honours outstanding oncology professionals 2Health News:ESMO honours outstanding oncology professionals 3
... WALTHAM, Mass., Oct. 13 Interleukin Genetics, Inc. (NYSE Amex: ... the fields of obesity and osteoporosis at medical meetings later this ... (ADA) Food and Nutrition Conference & Expo in Denver, Colo. ... IDF 20th World Diabetes Congress - Montreal, Canada . , ...
... ventilation be avoided during an infectious outbreak, the author ... ) in CMAJ ( Canadian Medical Association ... be used expeditiously in this setting. Noninvasive ... of patients in respiratory failure, rather than a tube ...
... ... a healthy neutral body posture by transforming existing office chairs into ergonomic computer workstations ... Salisbury, NC ... announced today the availability of the Mobo® , a revolutionary computer accessory that ...
... ... OxiTitan VLR : A new weapon in the battle against ... bacteria on treated surfaces. OxiTitan VLR is a broad spectrum mineral ... trap, oxidize and kill microbes. Safe and eco-friendly OxiTitan VLR is ...
... On Wednesday, October 14, the American Muslim Taskforce ... major national Islamic organizations, will host an "Interfaith Hearing ... D.C. , The hearing, which will include presentations by ... of Congress, is designed to mobilize support for "genuine ...
... The Blue Cross and Blue Shield of Georgia Foundation ... the Georgia Flood Relief Effort. , Strong storms and continued ... metro Atlanta and its surrounding areas - with more than ... Chattooga, Cherokee, Clayton, Cobb, Crawford, DeKalb, Douglas, Forsyth, Fulton, Gwinnett, ...
Cached Medicine News:Health News:Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings 2Health News:Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings 3Health News:Should noninvasive ventilation be considered a high-risk procedure during an epidemic? 2Health News:Ergobiz Announces The Mobo Ergonomic Computer Station 2Health News:Ergobiz Announces The Mobo Ergonomic Computer Station 3Health News:Independent Study: OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces 2Health News:Independent Study: OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces 3Health News:DC: Muslim Coalition to Host Interfaith Hearing on Health Care 2Health News:Blue Cross and Blue Shield of Georgia Foundation Donates $25,000 to Red Cross for Flood Relief Efforts in Georgia 2
(Date:8/21/2014)... 21, 2014   Memorial Hermann Health System and ... today announced a new partnership to provide a new level ... care centers in the greater Houston ... become the exclusive provider of professional breast radiology services for ... Memorial City, The Woodlands , Northeast, Southwest ...
(Date:8/21/2014)... , Aug. 21, 2014 Nektar Therapeutics ... Inc. today announced positive results from its Phase ... investigational, extended half-life recombinant factor VIII (rFVIII) treatment ... (Recombinant)], which met its primary endpoint in reducing ... compared to the on-demand arm. Top-line ...
(Date:8/21/2014)... , Aug. 21, 2014 The spinal column is ... human body. Signals carried to and from the brain through ... and nervous system. Injury or ailment here can be life ... a loss of control over their body. Though back injury ... person,s life, there are more options available to make things ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2
... (NYSE: WPI ), a leading specialty pharmaceutical ... Chief Executive Officer, will provide an overview and update ... Global Healthcare Conference on Tuesday, March 13, 2012 at ... in Miami, Florida.  The presentation will be webcast live ...
... March 1, 2012  Heritage Provider Network presented checks totaling ... Health Prize competition at the Strata Conference in Santa ... 12 month mark. Once again, the ... winning the top spot.  Players include David Vogel, CEO ...
Cached Medicine Technology:Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 2Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 3
... MRAnywhere stands for Medical ... Electronic Medical Records (EMR) software ... charts from within your office, ... Wide Web. MRAnywhere offers conversion ...
... Pro Software developed a touchscreen EHR and ... While a user can choose to use ... to maintain eye contact while recording encounter ... Pro EHR also runs on a pen ...
... designed to improve the efficiency and quality ... the ability to capture and recall patient ... audio or video formats. As an electronic ... contemporary windows interface and is compatible with ...
... Dairylands Clinical Information ... a suite of integrated ... clinical departments and automate ... tasks. The applications allow ...
Medicine Products: